Item 5.07 Submission of Matters to a Vote of Security Holders.
OnAugust 3, 2020 ,Menlo Therapeutics Inc. (the "Company") held its 2020 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on three proposals, each of which is described in more detail in the Company's definitive proxy statement filed with theSecurities and Exchange Commission onJune 22, 2020 . Only stockholders of record as of the close of business onJune 10, 2020 , the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 167,622,305 shares of the Company's common stock were outstanding and entitled to vote at the Annual Meeting. The following is a summary of the matters voted on at the Annual Meeting, including the approval percentage for each proposal, represented as a percentage of total votes cast for each such proposal, and for Proposal 3, the percentage of total shares outstanding that voted in favor
of the proposal. Proposal 1. The stockholders elected the following two directors to the Company's Board of Directors (the "Board"), to hold office until the 2023 annual meeting of stockholders or until their respective successors are elected. The voting results were as follows: Votes Nominee Votes For Withheld Broker Non-Votes Approval Percentage Sharon Barbari 84,804,720 1,130,463 39,045,741 99 % Rex Bright 84,864,133 1,071,050 39,045,741 99 %
Proposal 2. The stockholders ratified the appointment of
Votes For Votes Against Abstentions Broker Non-Votes Approval Percentage 122,493,089 1,315,205 1,172,630 0 99 % Proposal 3. The stockholders approved a proposal to adopt an amendment to the company's Amended and Restated Certificate of Incorporation to effect (a) a reverse stock split of the company's outstanding shares of common stock, at a reverse stock split ratio ranging from 1-for-2 to 1-for-7 shares, which may be determined by the Board at a later date, and (b) a reduction in the number of authorized shares of the Company's common stock by a corresponding ratio (collectively, the "reverse stock split proposal"). As of the date hereof, the Board has not made any determination on the filing of such amendment. The voting results were as follows: Percentage of Shares Approval
Votes For Votes Against Abstentions Broker Non-Votes Outstanding Percentage 110,553,351
13,624,684 802,889 0 66 % 89 %
© Edgar Online, source